GeoVax Labs, Inc. announced the appointment of Arban Domi, Ph.D., as its Director, Vector Development. Dr. Domi will not only be a key player in the continued development of GeoVax's HIV vaccines currently being evaluated in human clinical trials, but also in the development of versions of the Company's vaccines for the subtypes of HIV affecting the developing world. Dr. Domi's experience will also be instrumental in the company's evaluation of the suitability of vaccine constructs for commercial-scale vaccine manufacturing processes.